Yun-Ju Chen Selected Research

Small Interfering RNA (siRNA)

1/2014	Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells.
6/2008	Eps8 decreases chemosensitivity and affects survival of cervical cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Ju Chen Research Topics

Disease

30	Neoplasms (Cancer) 10/2023 - 12/2004
16	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2011
8	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 01/2013
6	Neoplasm Metastasis (Metastasis) 10/2023 - 09/2011
6	Carcinogenesis 01/2019 - 06/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2011
4	Macular Edema 07/2021 - 01/2016
4	Triple Negative Breast Neoplasms 11/2015 - 04/2013
3	Pain (Aches) 02/2024 - 11/2013
3	Stroke (Strokes) 03/2022 - 05/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2013
3	Prostatic Neoplasms (Prostate Cancer) 06/2017 - 12/2004
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2016 - 07/2013
3	Muscular Dystrophies (Muscular Dystrophy) 02/2007 - 06/2002
2	Retinal Detachment (Retinal Detachments) 01/2022 - 01/2018
2	Diabetes Mellitus 07/2021 - 01/2013
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2011
2	Oncogene Addiction 01/2018 - 11/2013
2	Colonic Neoplasms (Colon Cancer) 06/2008 - 07/2007
1	Osteoarthritis 02/2024
1	Weight Loss (Weight Reduction) 01/2024
1	Obesity 01/2024
1	Silicosis 10/2023
1	Squamous Cell Carcinoma of Head and Neck 10/2023
1	Vision Disorders (Hemeralopia) 10/2022
1	Panuveitis 10/2022
1	Scleritis (Episcleritis) 10/2022
1	White Dot Syndromes 10/2022
1	Anterior Uveitis 10/2022
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 10/2022
1	Retinal Artery Occlusion 10/2022
1	Anastomotic Leak 05/2022
1	Infections 02/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Bone Fractures (Bone Fracture) 01/2022
1	Uveal Effusion Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2002
10	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2011
9	Lapatinib (GW572016)FDA Link 01/2021 - 04/2013
8	ErbB Receptors (EGF Receptor)IBA 10/2023 - 06/2011
4	Phosphotransferases (Kinase)IBA 01/2021 - 04/2012
4	FlavonoidsIBA 08/2014 - 06/2013
3	Ranibizumab (Lucentis)FDA Link 07/2021 - 02/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 10/2012
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 03/2012
3	human ERBB2 proteinIBA 09/2016 - 04/2013
2	AndrogensIBA 01/2022 - 06/2017
2	Retinaldehyde (Retinal)IBA 01/2022 - 07/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
2	Proteasome InhibitorsIBA 09/2019 - 11/2013
2	chrysinIBA 02/2019 - 06/2018
2	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 01/2013
2	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2016
2	SmokeIBA 01/2018 - 03/2012
2	afliberceptIBA 01/2018 - 01/2016
2	MethyltransferasesIBA 01/2017 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 09/2016 - 11/2015
2	SERPIN-B5 (maspin)IBA 08/2016 - 09/2015
2	hepatitis B virus X proteinIBA 01/2016 - 04/2012
2	Small Interfering RNA (siRNA)IBA 01/2014 - 06/2008
2	AgarIBA 12/2013 - 06/2013
2	WYC02-9IBA 12/2013 - 06/2013
2	Mitogen-Activated Protein Kinase 14IBA 12/2013 - 06/2013
2	Estrogen ReceptorsIBA 11/2013 - 06/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2013 - 06/2012
2	NF-kappa B (NF-kB)IBA 11/2013 - 04/2012
2	protoapigenoneIBA 07/2013 - 06/2013
2	Oncogene Proteins (Oncogene Protein)IBA 10/2012 - 06/2008
2	Gefitinib (Iressa)FDA Link 06/2011 - 01/2011
2	Dystroglycans (Dystroglycan)IBA 02/2007 - 10/2003
1	Carbon DioxideIBA 02/2024
1	Collagen Type II (Type II Collagen)IBA 02/2024
1	SolutionsIBA 02/2024
1	Hyaluronic Acid (Hyaluronan)IBA 02/2024
1	QuartzIBA 10/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2023
1	NucleolinIBA 10/2023
1	IntegrinsIBA 10/2023
1	Fibronectins (Fibronectin)IBA 10/2023
1	Epidermal Growth Factor (EGF)IBA 10/2023
1	Heterogeneous-Nuclear Ribonucleoprotein Group A-BIBA 10/2023
1	VaccinesIBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2022
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022
1	Hematoxylin (Haematoxylon)IBA 02/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2022
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2011
2	Canes (Cane) 03/2022 - 04/2019
2	Injections 07/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 12/2013 - 01/2013
1	Meniscectomy 02/2024
1	High-Protein Diet 01/2024
1	Lung Transplantation 10/2023
1	Extracorporeal Shockwave Therapy 02/2022